Utilization of the Expanded Disability Status Scale as a distinctive instrument for walking impairment in persons with multiple sclerosis with mild disability
Restricted accessResearch articleFirst published online February 10, 2016
Utilization of the Expanded Disability Status Scale as a distinctive instrument for walking impairment in persons with multiple sclerosis with mild disability
The Expanded Disability Status Scale (EDSS) is a well-established clinical measure to assess disability in multiple sclerosis (MS). Gait dysfunction is primarily considered for scoring only above EDSS 3.5. However, the changes in functional systems in below EDSS 3.5 may result gait disturbances.
OBJECTIVE:
To determine the distinctive ability of the EDSS 2.0 in terms of walking impairment as well as fatigue, depression, and quality of life in persons with MS with mild disability.
METHODS:
All participants underwent the neurological examination for generating an EDSS score and completed the measures of walking performance, as well as other measures of fatigue, depression, and quality of life. The participants were divided into two groups according to the EDSS scores (i.e. EDSS <2.0 and 2.0–3.5).
RESULTS:
Participants with EDSS 2.0–3.5 had significantly worse walking performance, as well as fatigue, depression, and quality of life levels than the participants with EDSS <2.0 (p < 0.05). The EDSS significantly correlated with the measures of walking performance, as well as other measures of fatigue, depression, and quality of life.
CONCLUSIONS:
The EDSS 2.0 has a distinctive ability in terms of walking impairment as well as fatigue, depression, and quality of life.
AmatoM., PonzianiG., RossiF., LiedlC., StefanileC., & RossiL. (2001). Quality of life in multiple sclerosis: The impact of depression, fatigue and disability. Multiple Sclerosis, 7(5), 340–344.
2.
ArmutluK., KeserI., KorkmazN., AkbiyikD. I., SumbulogluV., GuneyZ., & KarabudakR. (2007). Psychometric study of Turkish version of Fatigue Impact Scale in multiple sclerosis patients. Journal of the Neurological Sciences, 255(1-2), 64–68.
3.
AronsonK. J. (1997). Quality of life among persons with multiple sclerosis and their caregivers. Neurology, 48(1), 74–80.
4.
ATSstatement: Guidelines for the six-minute walk test. (2002), American Journal of Respiratory and Critical Care Medicine, 166(1), 111–117.
5.
BeckA. T., SteerR. A., BallR., & RanieriW. (1996). Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. Journal of Personality Assessment, 67(3), 588–597.
6.
BethouxF., & BennettS. (2011). Evaluating Walking in Patients with Multiple Sclerosis: Which Assessment Tools Are Useful in Clinical Practice?. International Journal of MS Care, 13(1), 4–14.
7.
BjartmarC., KinkelR. P., KiddG., RudickR. A., & TrappB. D. (2001). Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology, 57(7), 1248–1252.
8.
ComiG. (2000). Why treat early multiple sclerosis patients?. Current Opinion in Neurology, 13(3), 235–240.
CorthalsA. P. (2011). Multiple sclerosis is not a disease of the immune system. The Quarterly Review of Biology, 86(4), 287–321.
11.
EriksenL., CurtisT., GrønbækM., HelgeJ. W., & TolstrupJ. S. (2013). The association between physical activity, cardiorespiratory fitness and self-rated health. Preventive Medicine, 57(6), 900–902.
12.
FischerJ. S., RudickR. A., CutterG. R., & ReingoldS. C. (1999). The Multiple Sclerosis Functional Composite Measure (MSFC): An integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Multiple Sclerosis, 5(4), 244–250.
13.
FiskJ. D., RitvoP. G., RossL., HaaseD. A., MarrieT. J., & SchlechW. F. (1994). Measuring the functional impact of fatigue: Initial validation of the fatigue impact scale. S. Clinical Infectious Diseases, 18(Suppl 1), 79–83.
14.
FryD. K., & PfalzerL. A. (2006). Reliability of Four Functional Tests and Rating of Perceived Exertion in Persons with Multiple Sclerosis. Physiotherapy Canada, 58(3), 212–220.
15.
HeineM., WensI., Langeskov-ChristensenM., VerschurenO., EijndeB. O., KwakkelG., & DalgasU. (2015). Cardiopulmonary fitness is related to disease severity in multiple sclerosis. Multiple Sclerosis, 1352458515581437.
16.
HobartJ. C., RiaziA., LampingD. L., FitzpatrickR., & ThompsonA. J. (2003). Measuring the impact of MS on walking ability: The 12-Item MS Walking Scale (MSWS-12). Neurology, 60(1), 31–36.
17.
JohanssonS., YtterbergC., ClaessonI. M., LindbergJ., HillertJ., AnderssonM., Widén HolmqvistL., & von KochL. (2007). High concurrent presence of disability in multiple sclerosis. Journal of Neurology, 254(6), 767–773.
18.
KahramanT., SavciS., Coskuner-PoyrazE., OzakbasS., & IdimanE. (2015). Determinants of physical activity in minimally impaired people with multiple sclerosis. Clinical Neurology and Neurosurgery, 138, 20–24.
19.
KapciE. G., UsluR., TurkcaparH., & KaraoglanA. (2008). Beck Depression Inventory II: Evaluation of the psychometric properties and cut-off points in a Turkish adult population. Depression and Anxiety, 25(10), E104–E110.
KurtzkeJ. F. (1983). Rating neurologic impairment in multiple sclerosis an expanded disability status scale (EDSS. Neurology, 33(11), 1444.
22.
KuspinarA., AndersenR. E., TengS. Y., AsanoM., & MayoN. E. (2010). Predicting exercise capacity through submaximal fitness tests in persons with multiple sclerosis. Archives of Physical Medicine and Rehabilitation, 91(9), 1410–1417.
23.
Lizrova PreiningerovaJ., NovotnaK., RuszJ., SuchaL., RuzickaE., & HavrdovaE. (2015). Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5). Journal of NeuroEngineering and Rehabilitation, 12, 14.
24.
MartinC. L., PhillipsB., KilpatrickT., ButzkuevenH., TubridyN., McDonaldE., & GaleaM. (2006). Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Multiple Sclerosis, 12(5), 620–628.
25.
Meyer-MoockS., FengY. S., MaeurerM., DippelF. W., & KohlmannT. (2014). Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis. BMC Neurology, 14, 58.
26.
NieuwenhuisM. M., Van TongerenH., SorensenP. S., & RavnborgM. (2006). The six spot step test: A new measurement for walking ability in multiple sclerosis. Multiple Sclerosis, 12(4), 495–500.
27.
PavanK., TilberyC. P., LianzaS., & MarangoniB. E. (2010). Validation of the “Six Step Spot Test” for gait among patients with multiple sclerosis in Brazil. Arquivos de Neuro-Psiquiatria, 68(2), 198–204.
28.
ProvincialiL., CeravoloM., BartoliniM., LogulloF., & DanniM. (1999). A multidimensional assessment of multiple sclerosis: Relationships between disability domains. Acta Neurologica Scandinavica, 100(3), 156–162.
29.
RombergA., VirtanenA., AunolaS., KarppiS. L., KarankoH., & RuutiainenJ. (2004). Exercise capacity, disability and leisure physical activity of subjects with multiple sclerosis. Multiple Sclerosis, 10(2), 212–218.
30.
SandroffB. M., MotlR. W., SosnoffJ. J., & PulaJ. H. (2015). Further validation of the Six-Spot Step Test as a measure of ambulation in multiple sclerosis. Gait & Posture, 41(1), 222–227.
31.
SandroffB. M., PiluttiL. A., & MotlR. W. (2015). Does the six-minute walk test measure walking performance or physical fitness in persons with multiple sclerosis?. NeuroRehabilitation, 37(1), 149–155.
32.
SavciS., Inal-InceD., ArikanH., Guclu-GunduzA., Cetisli-KorkmazN., ArmutluK., & KarabudakR. (2005). Six-minute walk distance as a measure of functional exercise capacity in multiple sclerosis. Disability and Rehabilitation, 27(22), 1365–1371.
33.
SimeoniM., AuquierP., FernandezO., FlacheneckerP., StecchiS., ConstantinescuC., IdimanE., BoykoA., BeiskeA., VollmerT., TriantafyllouN., O’ConnorP., BarakY., BiermannL., CristianoE., AtwehS., PatrickD., RobitailS., AmmouryN., BeresniakA., & PelletierJ. (2008). Validation of the Multiple Sclerosis International Quality of Life questionnaire. Multiple Sclerosis, 14(2), 219–230.
34.
SkokouM., SoubasiE., & GourzisP. (2012). Depression in multiple sclerosis: A review of assessment and treatment approaches in adult and pediatric populations. ISRN Neurology, 2012, 427102.
35.
ThoumieP., LamotteD., CantalloubeS., FaucherM., & AmarencoG. (2005). Motor determinants of gait in 100 ambulatory patients with multiple sclerosis. Multiple Sclerosis, 11(4), 485–491.
36.
WhiteL. J., & CastellanoV. (2008). Exercise and Brain Health—Implications for Multiple Sclerosis. Sports Medicine, 38(3), 179–186.
